SCHEMBL239261

SCHEMBL239261

Clc1ccc2c(c1)Sc1ccccc1N2

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 12/20 0.79
BCHE P06276 3/20 0.79
ACHE P22303 3/20 0.79
MAPT P10636 6/20 0.65
GAA P10253 5/20 0.65
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
SNCA P37840 3/20 0.65
TDP1 Q9NUW8 2/20 0.65
ALOX15 P16050 2/20 0.65
CYP1A2 P05177 1/20 0.65
POLB P06746 1/20 0.65
CYP3A4 P08684 1/20 0.65
ADORA3 P0DMS8 1/20 0.65
ALOX12 P18054 1/20 0.65
MAOA P21397 1/20 0.65
CNR1 P21554 1/20 0.65
PTGS1 P23219 1/20 0.65
SLC6A2 P23975 1/20 0.65
HTR2C P28335 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30769670 1.00 NOX1 (0.79) NOX1BCHEACHEMAPTGAA
SCHEMBL1509784 0.92 NOX1 (0.68) NOX1BCHEACHEMAPTGAA
SCHEMBL30697368 0.90 NOX1 (0.62) NOX1BCHEACHEMAPTGAA
SCHEMBL7673182 0.90 NOX1 (0.62) NOX1BCHEACHEMAPTGAA
SCHEMBL28091291 0.89 NOX1 (0.64) NOX1BCHEACHEMAPTGAA
SCHEMBL236458 0.89 NOX1 (1.00) NOX1BCHEACHEMAPTGAA
SCHEMBL29384266 0.89 NOX1 (1.00) NOX1BCHEACHEMAPTGAA
Hydrochloric Acid SCHEMBL20495637 0.88 NOX1 (0.60) NOX1BCHEACHEMAPTGAA
Hydrochloric Acid SCHEMBL30448208 0.88 NOX1 (0.60) NOX1BCHEACHEMAPTGAA
SCHEMBL28679021 0.87 NOX1 (0.96) NOX1BCHEACHEMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5486582-A Polymer scale preventive process using a coating of chitosan salt and phenothiazine SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-01-23 US claimed
US-20250376556-A1 Curable Epoxy Resin Compositions with High Glass Transition Tempature HUNTSMAN ADVANCED MAT AMERICAS LLC (US) 2025-12-11 US disclosed
CN-119487097-A Curable epoxy resin composition with high glass transition temperature 亨斯迈先进材料美国有限责任公司 2025-02-18 CN disclosed
CN-117327028-B Phenothiazine derivative, pharmaceutical composition and application thereof in treating echinococcosis 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 2024-07-23 CN disclosed
WO-2024006101-A2 CURABLE EPOXY RESIN COMPOSITIONS WITH HIGH GLASS TRANSITION TEMPERATURE HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) 2024-01-04 WO disclosed
CN-117327028-A Phenothiazine derivative, pharmaceutical composition and application thereof in treating echinococcosis 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) 2024-01-02 CN disclosed
EP-3143067-B1 MULTIFUNCTIONAL POLYAMIDES FOR PROTECTIVE COATINGS HUNTSMAN ADVANCED MAT AMERICAS LLC (US) 2023-09-13 EP disclosed
US-11524970-B2 Nitrogen-containing compound, electronic element, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-12-13 US disclosed
US-11524970-B2 Nitrogen-containing compound, electronic element, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-12-13 US disclosed
US-20220213124-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-07 US disclosed
US-6114392-A A NORBORNANE DERIVATIVES FOR REDUCING THE SIDE EFFECT OF AGMATINE, IN THE TREATMENT OF STROKE AND DEMENTIA GILAD GAD M (IL) 2000-09-05 US disclosed
US-5677349-A ADMINSTERING IN THE TREATMENT OF STROKE AND DEMENTIA GILAD GAD M (IL) 1997-10-14 US disclosed
EP-0517656-B1 Fire-protected polyimide composition CIBA GEIGY AG (CH) 1997-08-20 EP disclosed
US-5637387-A PREPOLYMER OF BISMALEIMIDE AND ALKENYLPHENOL STABILIZED WITH PHENOTHIAZINE OR DERIVATIVE THEREOF OR HYDROQUINONE CIBA-GEIGY CORPORATION (US) 1997-06-10 US disclosed
US-5486582-A Polymer scale preventive process using a coating of chitosan salt and phenothiazine SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-01-23 US disclosed
US-5240981-A Blend with alkenylphenol, tribromophenylmaleimide, free radical catalyst, and phenothiazine derivative CIBA-GEIGY CORPORATION (US) 1993-08-31 US disclosed
EP-0517656-A2 Fire-protected polyimide composition CIBA-GEIGY AG (CH) 1992-12-09 EP disclosed
US-4115571-A DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS MEAD JOHNSON & COMPANY (US) 1978-09-19 US disclosed
US-4077959-A DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC MEAD JOHNSON & COMPANY (US) 1978-03-07 US disclosed
US-3946004-A DIURETICS, MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS MEAD JOHNSON & COMPANY (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524970-B2 Nitrogen-containing compound, electronic element, and electronic device OCIAD1, OCIAD2, JUND NOX1 34/4885BCHE 1442/4885ACHE 1330/4885
US-20220213124-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE OCIAD1, OCIAD2, JUND NOX1 34/4885BCHE 1442/4885ACHE 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.